All lobbying filings

THE DUBERSTEIN GROUP INC.

THE DUBERSTEIN GROUP INC. filed a Q3 report for GILEAD SCIENCES, INC. on October 19, 2026, reporting $90,000 in lobbying income.

Lobbying for GILEAD SCIENCES, INC. · Biotechnology company that researches, develops and commercializes drugs.

All filings by THE DUBERSTEIN GROUP INC. · Everything GILEAD SCIENCES, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

SAMUEL SCALES

Previously held: Senior Advisor, USTR (2025); Deputy Assistant, USTR (2019-2020); Coalitions Director, House Natural Resources (2015-2016)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to drug pricing

Trade (domestic/foreign)

Issues related to MFN pricing and trade

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.